Proteomic studies of urinary biomarkers for prostate, bladder and kidney cancers
Authors:
- Steven L. WoodSWSteven L. Wood
- Margaret A. KnowlesMKMargaret A. Knowles
- Douglas ThompsonDTDouglas Thompson
- Peter J. SelbyPSPeter J. Selby
- Rosamonde E. BanksRBRosamonde E. Banks
- 26 February 2013
- journal article
- review article
- Published by Springer Nature in Nature Reviews Urology
- Vol. 10 (4) , 206-218
Abstract
Urine is an ideal body fluid for the detection of protein markers produced by urological cancers as it can be sampled noninvasively and contains secreted and directly shed proteins from the prostate, bladder and kidney. Major challenges of working with urine include high inter-individual and intra-individual variability, low protein concentration, the presence of salts and the dynamic range of protein expression. Despite these challenges, significant progress is being made using modern proteomic methods to identify and characterize protein-based markers for urological cancers. The development of robust, easy-to-use clinical tests based on novel biomarkers has the potential to impact upon diagnosis, prognosis and monitoring and could revolutionize the treatment and management of these cancers.Keywords
This publication has 123 references indexed in Scilit:
- Proteomic analysis of urine exosomes by multidimensional protein identification technology (MudPIT)Proteomics, 2011
- Characterization of ADAM28 as a biomarker of bladder transitional cell carcinomas by urinary proteome analysisBiochemical and Biophysical Research Communications, 2011
- Taking a new biomarker into routine use – A perspective from the routine clinical biochemistry laboratoryProteomics – Clinical Applications, 2010
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008International Journal of Cancer, 2010
- Comprehensive human urine standards for comparability and standardization in clinical proteome analysisProteomics – Clinical Applications, 2010
- Bikunin Loss in Urine as Useful Marker for Bladder CarcinomaJournal of Urology, 2010
- Urine proteomics for profiling of human disease using high accuracy mass spectrometryProteomics – Clinical Applications, 2009
- Clinical collection and protein properties of expressed prostatic secretions as a source for biomarkers of prostatic diseaseJournal of Proteomics, 2009
- Discovery and validation of urinary biomarkers for prostate cancerProteomics – Clinical Applications, 2008
- Detection of pre-neoplastic and neoplastic prostate disease by MADI profiling of urineBiochemical and Biophysical Research Communications, 2006